New Long-Acting shot for schizophrenia enters early human testing
Disease control
Recruiting now
This early-stage study is testing a single injection of a long-acting form of the drug brexpiprazole in healthy volunteers and people with schizophrenia. The main goal is to check if the injection is safe and tolerable, and how the body processes the drug. The trial involves 56 p…
Phase: PHASE1 • Sponsor: Sichuan Kelun Pharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC